Elizabeth Bayliss to Deprescriptions
This is a "connection" page, showing publications Elizabeth Bayliss has written about Deprescriptions.
Connection Strength
3.753
-
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize Trial. Drugs Aging. 2024 Jan; 41(1):45-54.
Score: 0.909
-
Perspectives on Deprescribing Communication in Primary Care. J Gen Intern Med. 2021 04; 36(4):1122.
Score: 0.757
-
Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative Study. J Gen Intern Med. 2020 12; 35(12):3556-3563.
Score: 0.723
-
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Trials. 2020 Jun 18; 21(1):542.
Score: 0.717
-
Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia. JAMA Netw Open. 2023 10 02; 6(10):e2336728.
Score: 0.225
-
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed. Age Ageing. 2023 01 08; 52(1).
Score: 0.214
-
Deprescribing medications: Do out-of-pocket costs have a role? J Am Geriatr Soc. 2022 11; 70(11):3334-3337.
Score: 0.208